Precision Diagnostics for Personalized Cancer Therapy
We are on a mission to transform cancer therapy.
At Encapsulate, we deliver evidence-driven insights from each patient’s therapeutic response profile to determine the most effective clinical treatment regimen on a personalized basis.
Our Team
Armin Rad, PhD
Co-founder and CEO
Ph.D. in Cancer Nanomedicine
MBA in Global Entrepreneurship
2 patents and 25+ peer-reviewed articles
Leila Daneshmandi, PhD
Co-founder and COO
Ph.D. in Tissue Regeneration
MBA in Global Entrepreneurship
Faculty of Innovation and Entrepreneurship, UConn
Bret Schipper, MD, FACS
CMO
CMO
Vice President and Co-physician in Chief of the Digestive Health Institute Hartford Healthcare, Chief of Surgical Oncology at Hartford Hospital and Director of Oncologic Surgery for the Cancer Institute
Duran Gonzalez
Head of R&D
PhD in Biomedical Engineering, MSc in Genetics, BSc in Biology, 5+ years of experience in sequencing
Farnoosh Saeedinejad
Research Assistant
MSc in Tissue Engineering, 4+ years experience in microfluidic devices, cancer biology, cancer imaging
John Strahley, MBA
CFO
Senior strategic, financial, and operational executive with over 25 years of broad industry experience
Joel Levine, MD
Director of Creativity, CSO
Medical Oncologist,
Founding Director, Colon Cancer Prevention Program at UConn Health
Advisory Board
Reza Amin, PhD
Co-founder
Ph.D. in Mechanical Engineering
MBA in Global Entrepreneurship
10+ yrs experience in medical devices
Gerald F. Vovis, PhD
President and CEO at Vovis Enterprises
Biotech consultant and executive in residence at Connecticut Innovations
Vivek Ramakrishnan, PhD
Former Managing Partner, New Ventures at Ventech Solutions
10+ years experience in private equity, venture capital, and medical device development
John Kallassy, MBA
Managing Partner at Aimers Venture Partners
Experienced CEO and CFO in Biotech
Daniel Wagner, MBA
Board of Directors
Early Stage Life Science Investor and Board Member
Chris Willenken
Board of Directors
Partner, Blackwood Healthcare Breakthroughs
Mason Reiner, MBA
Board of Directors
Partner @ Ambit Health Ventures | Investing in early-stage digital health
Scientific Advisory Board
Raman Bahal, PhD
Associate Professor, UConn School of Pharmacy
Targeted therapies, novel delivery methods for cancer therapy, gene correction based technologies
Mu-Ping Nieh, PhD
Professor, UConn School of Engineering
Theranostic nanocarriers, Drug delivery, Structural characterization
Alvaro Menendez, MD
Medical Oncology, Hartford Healthcare
Hematology, Oncology, High Risk Patients, Cancer Prevention,
Ali Tamayol, PhD
Associate Professor, UConn School of Engineering
Biomanufacturing, Microtechnologies, Automated systems
Sasan Jalili, PhD
Assistant Professor, JAX Laboratory; MIT Koch Institute for Integrative Cancer Research
Immune Engineering, Diagnostics, Organ-on-chips
Charles Giardina, PhD
Professor, UConn Molecular and Cell Biology
Cancer molecular biology, cell regulation, cell proliferation and death
John Birk, MD
Clinical Advisor
Medical Oncologist, GI tract
Division Of Gastroenterology at University of Connecticut Health Center
Rawad Elias, MD
Medical Director of Geriatric Oncology, Hartford Healthcare Cancer Institute
Colorectal, Pancreatic, Gastric, Gastrointestinal, Esophageal, and Liver Cancers Oncologist.
Chief Hematology-Oncology & Director Cancer Services at Baystate Health
Investors
